NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Back to search
Official data from USPTO
MAKING GETTING BETTER, BETTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MAKING GETTING BETTER, BETTER
ST13
US500000088241730Class
5, 35, 41, 42, 44
Filing
88241730
Registration
7108076
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
07/11/2023
Trademark type
Word
Nice classes
5, 35, 41, 42, 44
Filing date
12/26/2018
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/06/2022
First use in commerce
07/06/2022
Drawing code
4
Owner type
03
Owner location
Washington, DC, US
Examiner
MCCARTHY, JOSEPH PATRICK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Patel & Gong, Inc.
Patel & Gong, Inc.
Representatives
Francis G. Gleason, Jr. GLEASON & GLEASON, P.C.
Technical classification
Nice Classes
Class 5Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsan analgesic for human consumption taken orally; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsantivirals; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparationsinjectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Analgesic and muscle relaxant pharmaceutical preparations
Class 35
Retail pharmacy services; Retail store services for pharmaceutical preparations and medical supplies
Class 41
Providing a website featuring blogs and non-downloadable publications in the nature of magazinesbrochuresarticles in the field(s) of pharmaceuticalsmedicinehealthcaredisease managementnutritiondietfitnesspersonal health
Class 42
Providing online non-downloadable mobile applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers
Class 44
Hygienic and beauty care; Medical services; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; Providing a web site featuring information in the field of mental health and physical healthincluding living a healthy and disease free life; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks
Publications
History of USPTO decisions and trademark events.
66 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/05/2023
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
06/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2023
GNRT
NON-FINAL ACTION E-MAILED
02/22/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/22/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/02/2023
IUAF
USE AMENDMENT FILED
01/30/2023
EISU
TEAS STATEMENT OF USE RECEIVED
01/30/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/02/2022
EX5G
SOU EXTENSION 5 GRANTED
08/01/2022
EXT5
SOU EXTENSION 5 FILED
07/27/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/27/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2022
EX4G
SOU EXTENSION 4 GRANTED
04/29/2022
NREV
NOTICE OF REVIVAL - E-MAILED
04/27/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
04/27/2022
PETG
PETITION TO REVIVE-GRANTED
04/27/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
04/27/2022
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02/28/2022
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/28/2022
EXT4
SOU EXTENSION 4 FILED
01/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/02/2021
EX3G
SOU EXTENSION 3 GRANTED
11/01/2021
NREV
NOTICE OF REVIVAL - E-MAILED
10/30/2021
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
10/29/2021
PETG
PETITION TO REVIVE-GRANTED
10/29/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
10/29/2021
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/30/2021
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/30/2021
EXT3
SOU EXTENSION 3 FILED
07/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2021
EX2G
SOU EXTENSION 2 GRANTED
05/26/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/25/2021
NREV
NOTICE OF REVIVAL - E-MAILED
05/01/2021
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
04/30/2021
PETG
PETITION TO REVIVE-GRANTED
04/30/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
04/30/2021
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
03/01/2021
ABN6
ABANDONMENT - NO USE STATEMENT FILED
03/01/2021
EXT2
SOU EXTENSION 2 FILED
01/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/30/2020
EX1G
SOU EXTENSION 1 GRANTED
07/28/2020
EXT1
SOU EXTENSION 1 FILED
07/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/28/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2019
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2019
ALIE
ASSIGNED TO LIE
10/30/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2019
GNRT
NON-FINAL ACTION E-MAILED
04/01/2019
CNRT
NON-FINAL ACTION WRITTEN
04/01/2019
RFTP
REMOVED FROM TEAS PLUS
04/01/2019
DOCK
ASSIGNED TO EXAMINER
03/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/31/2019
NWAP
NEW APPLICATION ENTERED
12/29/2018
Continuous trademark protection
Get notified about every new filing that threatens MAKING GETTING BETTER, BETTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.